Additional information
| Active substance | Semaglutide |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Low risk |
| Lab Test | Blood glucose levels, HbA1c |
| Also known as | N/A |
| Blood pressure | Can cause a reduction in blood pressure |
| Trade name | Ozempic, Rybelsus |
| Storage conditions | Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F) |
| Chemical name | Semaglutide |
| Formula | C187H291N45O59 |
| Substance class | GLP-1 receptor agonist |
| Main action | Lowers blood glucose levels |
| Half-life | Approximately 1 week |
| Dosage (medical) | 0.25 mg once weekly, increasing to 0.5 mg and up to 1 mg as tolerated and needed |
| Dosage (sports) | Not recommended for use in sports |
| Effects | Improved glycemic control, weight loss |
| Side effects | Nausea, vomiting, diarrhea, abdominal pain, decreased appetite |
| Use in sports | None, not indicated for performance enhancement |
| Manufacturer | Beligas Pharmaceuticals |
| Packing | 5mg/vial |
LACIPIL 4 mg Glaxosmithkline
Zimaks 400 Bilim
Balkan Pharma Danabol 50 mg 60 Tabletten
Seretide Disckus (Advair) 250 mcg Glaxosmithkline
Avory Pharma Sustanon 300mg 10ml
Clenbutaxyl Kalpa Pharmaceuticals
Fostimon (Merional) 150 IU HMG IBSA
LASIX TABLET Aventis
Hardcore - xDrop Omega Lab
Dark Labs Double Yohimbine Dark Labs
CLENBOLIC Cooper Pharma
Sibutramine Magnus Pharmaceuticals
FUCIDIN 500 mg Abdi Ibragim
Clenodex Sciroxx
GLUCOPHAGE Merckgroup 

Reviews
There are no reviews yet.